For example, Seattle Genetics (SGN)-LIV1A or ladiratuzumab vedotin (LV), is currently in clinical trials for metastatic BC.156,601 LIV-1, also called ZIP6, is a transmembrane protein overexpressing in BC. This evidence concerns the gene SLC39A6 and breast cancer.